- Barclays analyst Benjamin Theurer downgraded Coca-Cola Femsa SAB de CV (NYSE: KOF) from Overweight to Equal-Weight and maintained the price target of $98. Coca-Cola Femsa shares closed at $87.60 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Tejas Savant downgraded 10x Genomics, Inc. (NASDAQ: TXG) from Overweight to Equal-Weight and raised the price target from $17 to $20. 10x Genomics shares closed at $18.08 on Monday. See how other analysts view this stock.
Considering buying KOF stock? Here’s what analysts think:
- Barclays analyst Benjamin Theurer downgraded **Coca-Cola Femsa SAB de CV** (NYSE: KOF) from Overweight to Equal-Weight and maintained the price target of $98. Coca-Cola Femsa shares closed at $87.60 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Tejas Savant downgraded **10x Genomics, Inc.** (NASDAQ: TXG) from Overweight to Equal-Weight and raised the price target from $17 to $20. 10x Genomics shares closed at $18.08 on Monday. See how other analysts view this stock.
Considering buying KOF stock? Here’s what analysts think:
<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul class="wp-block-list">
<li>Barclays analyst Benjamin Theurer downgraded <strong>Coca-Cola Femsa SAB de CV</strong> <a href="https://www.benzinga.com/quote/KOF" target="_blank" class="ticker-link" data-ticker="KOF" data-exchange="NYSE">(NYSE:<a class="ticker" href="https://www.benzinga.com/quote/KOF">KOF</a>)</a> from Overweight to Equal-Weight and maintained the price target of $98. Coca-Cola Femsa shares closed at $87.60 on Monday. <a href="https://www.benzinga.com/quote/KOF/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Tejas Savant downgraded <strong>10x Genomics, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/TXG">TXG</a>) from Overweight to Equal-Weight and raised the price target from $17 to $20. 10x Genomics shares closed at $18.08 on Monday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p>Considering buying KOF stock? Here’s what analysts think: </p>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/KOF/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="617" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02085752/image-3-17-1024x617.png" alt="" class="wp-image-1193050" style="width:632px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02085752/image-3-17-1024x617.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02085752/image-3-17-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02085752/image-3-17-768x463.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/12/02085752/image-3-17.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<p><strong>Read This Next:<a href="https://www.benzinga.com/trading-ideas/dividends/25/12/49157371/how-to-earn-500-a-month-from-american-eagle-stock-ahead-of-q3-earnings"> </a></strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/trading-ideas/dividends/25/12/49157371/how-to-earn-500-a-month-from-american-eagle-stock-ahead-of-q3-earnings">How To Earn $500 A Month From American Eagle Stock Ahead Of Q3 Earnings</a></strong></li>
</ul>
<p>Photo via Shutterstock</p>